nodes	percent_of_prediction	percent_of_DWPC	metapath
Sofosbuvir—ABCB1—Methylprednisolone—ankylosing spondylitis	0.263	0.279	CbGbCtD
Sofosbuvir—ABCB1—Betamethasone—ankylosing spondylitis	0.171	0.182	CbGbCtD
Sofosbuvir—ABCB1—Prednisolone—ankylosing spondylitis	0.169	0.179	CbGbCtD
Sofosbuvir—ABCB1—Prednisone—ankylosing spondylitis	0.159	0.169	CbGbCtD
Sofosbuvir—ABCB1—Dexamethasone—ankylosing spondylitis	0.0994	0.106	CbGbCtD
Sofosbuvir—ABCB1—Methotrexate—ankylosing spondylitis	0.0798	0.0849	CbGbCtD
Sofosbuvir—Suicidal ideation—Methylprednisolone—ankylosing spondylitis	0.00137	0.0229	CcSEcCtD
Sofosbuvir—Suicidal ideation—Betamethasone—ankylosing spondylitis	0.00125	0.0209	CcSEcCtD
Sofosbuvir—Suicidal ideation—Dexamethasone—ankylosing spondylitis	0.00125	0.0209	CcSEcCtD
Sofosbuvir—Suicidal ideation—Prednisone—ankylosing spondylitis	0.00108	0.0182	CcSEcCtD
Sofosbuvir—Memory impairment—Prednisone—ankylosing spondylitis	0.000969	0.0162	CcSEcCtD
Sofosbuvir—Dry skin—Prednisolone—ankylosing spondylitis	0.000697	0.0117	CcSEcCtD
Sofosbuvir—Irritability—Methylprednisolone—ankylosing spondylitis	0.000666	0.0111	CcSEcCtD
Sofosbuvir—Migraine—Dexamethasone—ankylosing spondylitis	0.000624	0.0105	CcSEcCtD
Sofosbuvir—Migraine—Betamethasone—ankylosing spondylitis	0.000624	0.0105	CcSEcCtD
Sofosbuvir—Irritability—Dexamethasone—ankylosing spondylitis	0.000605	0.0101	CcSEcCtD
Sofosbuvir—Irritability—Betamethasone—ankylosing spondylitis	0.000605	0.0101	CcSEcCtD
Sofosbuvir—Dry skin—Dexamethasone—ankylosing spondylitis	0.000581	0.00973	CcSEcCtD
Sofosbuvir—Dry skin—Betamethasone—ankylosing spondylitis	0.000581	0.00973	CcSEcCtD
Sofosbuvir—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.000537	0.009	CcSEcCtD
Sofosbuvir—Infestation—Methylprednisolone—ankylosing spondylitis	0.000537	0.009	CcSEcCtD
Sofosbuvir—Irritability—Prednisone—ankylosing spondylitis	0.000527	0.00883	CcSEcCtD
Sofosbuvir—Dry skin—Prednisone—ankylosing spondylitis	0.000506	0.00848	CcSEcCtD
Sofosbuvir—Weight decreased—Betamethasone—ankylosing spondylitis	0.000496	0.0083	CcSEcCtD
Sofosbuvir—Weight decreased—Dexamethasone—ankylosing spondylitis	0.000496	0.0083	CcSEcCtD
Sofosbuvir—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.000474	0.00794	CcSEcCtD
Sofosbuvir—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.000451	0.00755	CcSEcCtD
Sofosbuvir—Neutropenia—Prednisone—ankylosing spondylitis	0.000446	0.00747	CcSEcCtD
Sofosbuvir—Irritability—Methotrexate—ankylosing spondylitis	0.000441	0.00738	CcSEcCtD
Sofosbuvir—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.000435	0.00728	CcSEcCtD
Sofosbuvir—Weight decreased—Prednisone—ankylosing spondylitis	0.000432	0.00723	CcSEcCtD
Sofosbuvir—Vision blurred—Prednisolone—ankylosing spondylitis	0.000431	0.00722	CcSEcCtD
Sofosbuvir—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.00042	0.00703	CcSEcCtD
Sofosbuvir—Eye disorder—Betamethasone—ankylosing spondylitis	0.00041	0.00686	CcSEcCtD
Sofosbuvir—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00041	0.00686	CcSEcCtD
Sofosbuvir—Back pain—Triamcinolone—ankylosing spondylitis	0.000407	0.00682	CcSEcCtD
Sofosbuvir—Alopecia—Dexamethasone—ankylosing spondylitis	0.000388	0.00649	CcSEcCtD
Sofosbuvir—Alopecia—Betamethasone—ankylosing spondylitis	0.000388	0.00649	CcSEcCtD
Sofosbuvir—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.000382	0.0064	CcSEcCtD
Sofosbuvir—Pancytopenia—Methotrexate—ankylosing spondylitis	0.000379	0.00634	CcSEcCtD
Sofosbuvir—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000375	0.00629	CcSEcCtD
Sofosbuvir—Neutropenia—Methotrexate—ankylosing spondylitis	0.000373	0.00625	CcSEcCtD
Sofosbuvir—Cough—Triamcinolone—ankylosing spondylitis	0.000367	0.00615	CcSEcCtD
Sofosbuvir—Myalgia—Triamcinolone—ankylosing spondylitis	0.000358	0.006	CcSEcCtD
Sofosbuvir—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000358	0.00599	CcSEcCtD
Sofosbuvir—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000358	0.00599	CcSEcCtD
Sofosbuvir—Eye disorder—Prednisone—ankylosing spondylitis	0.000357	0.00598	CcSEcCtD
Sofosbuvir—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000356	0.00597	CcSEcCtD
Sofosbuvir—Infestation—Methotrexate—ankylosing spondylitis	0.000356	0.00595	CcSEcCtD
Sofosbuvir—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000356	0.00595	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000355	0.00594	CcSEcCtD
Sofosbuvir—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00035	0.00587	CcSEcCtD
Sofosbuvir—Infection—Triamcinolone—ankylosing spondylitis	0.000341	0.00571	CcSEcCtD
Sofosbuvir—Infection—Methylprednisolone—ankylosing spondylitis	0.00034	0.0057	CcSEcCtD
Sofosbuvir—Insomnia—Prednisolone—ankylosing spondylitis	0.000338	0.00566	CcSEcCtD
Sofosbuvir—Alopecia—Prednisone—ankylosing spondylitis	0.000338	0.00565	CcSEcCtD
Sofosbuvir—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000336	0.00563	CcSEcCtD
Sofosbuvir—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000336	0.00563	CcSEcCtD
Sofosbuvir—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000333	0.00557	CcSEcCtD
Sofosbuvir—Malnutrition—Prednisone—ankylosing spondylitis	0.000333	0.00557	CcSEcCtD
Sofosbuvir—Myalgia—Dexamethasone—ankylosing spondylitis	0.000325	0.00544	CcSEcCtD
Sofosbuvir—Myalgia—Betamethasone—ankylosing spondylitis	0.000325	0.00544	CcSEcCtD
Sofosbuvir—Anxiety—Betamethasone—ankylosing spondylitis	0.000324	0.00542	CcSEcCtD
Sofosbuvir—Anxiety—Dexamethasone—ankylosing spondylitis	0.000324	0.00542	CcSEcCtD
Sofosbuvir—Pain—Prednisolone—ankylosing spondylitis	0.000319	0.00535	CcSEcCtD
Sofosbuvir—Vision blurred—Prednisone—ankylosing spondylitis	0.000313	0.00525	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000313	0.00524	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000312	0.00523	CcSEcCtD
Sofosbuvir—Insomnia—Triamcinolone—ankylosing spondylitis	0.000311	0.0052	CcSEcCtD
Sofosbuvir—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00031	0.00519	CcSEcCtD
Sofosbuvir—Infection—Betamethasone—ankylosing spondylitis	0.00031	0.00518	CcSEcCtD
Sofosbuvir—Infection—Dexamethasone—ankylosing spondylitis	0.00031	0.00518	CcSEcCtD
Sofosbuvir—Anaemia—Prednisone—ankylosing spondylitis	0.000307	0.00515	CcSEcCtD
Sofosbuvir—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000306	0.00513	CcSEcCtD
Sofosbuvir—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000306	0.00512	CcSEcCtD
Sofosbuvir—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000306	0.00512	CcSEcCtD
Sofosbuvir—Agitation—Prednisone—ankylosing spondylitis	0.000306	0.00512	CcSEcCtD
Sofosbuvir—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000302	0.00506	CcSEcCtD
Sofosbuvir—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000302	0.00505	CcSEcCtD
Sofosbuvir—Eye disorder—Methotrexate—ankylosing spondylitis	0.000298	0.005	CcSEcCtD
Sofosbuvir—Fatigue—Triamcinolone—ankylosing spondylitis	0.000296	0.00496	CcSEcCtD
Sofosbuvir—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000295	0.00495	CcSEcCtD
Sofosbuvir—Pain—Triamcinolone—ankylosing spondylitis	0.000294	0.00492	CcSEcCtD
Sofosbuvir—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000288	0.00482	CcSEcCtD
Sofosbuvir—Chills—Methotrexate—ankylosing spondylitis	0.000286	0.0048	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000284	0.00475	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000284	0.00475	CcSEcCtD
Sofosbuvir—Arthralgia—Prednisone—ankylosing spondylitis	0.000283	0.00474	CcSEcCtD
Sofosbuvir—Myalgia—Prednisone—ankylosing spondylitis	0.000283	0.00474	CcSEcCtD
Sofosbuvir—Anxiety—Prednisone—ankylosing spondylitis	0.000282	0.00472	CcSEcCtD
Sofosbuvir—Alopecia—Methotrexate—ankylosing spondylitis	0.000282	0.00472	CcSEcCtD
Sofosbuvir—Insomnia—Betamethasone—ankylosing spondylitis	0.000282	0.00472	CcSEcCtD
Sofosbuvir—Insomnia—Dexamethasone—ankylosing spondylitis	0.000282	0.00472	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000281	0.00471	CcSEcCtD
Sofosbuvir—Malnutrition—Methotrexate—ankylosing spondylitis	0.000278	0.00465	CcSEcCtD
Sofosbuvir—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000274	0.00459	CcSEcCtD
Sofosbuvir—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000274	0.00459	CcSEcCtD
Sofosbuvir—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000272	0.00455	CcSEcCtD
Sofosbuvir—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000271	0.00454	CcSEcCtD
Sofosbuvir—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000271	0.00454	CcSEcCtD
Sofosbuvir—Infection—Prednisone—ankylosing spondylitis	0.00027	0.00451	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000269	0.00451	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000269	0.00451	CcSEcCtD
Sofosbuvir—Back pain—Methotrexate—ankylosing spondylitis	0.000269	0.0045	CcSEcCtD
Sofosbuvir—Fatigue—Dexamethasone—ankylosing spondylitis	0.000269	0.0045	CcSEcCtD
Sofosbuvir—Fatigue—Betamethasone—ankylosing spondylitis	0.000269	0.0045	CcSEcCtD
Sofosbuvir—Pain—Dexamethasone—ankylosing spondylitis	0.000267	0.00446	CcSEcCtD
Sofosbuvir—Pain—Betamethasone—ankylosing spondylitis	0.000267	0.00446	CcSEcCtD
Sofosbuvir—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000266	0.00446	CcSEcCtD
Sofosbuvir—Skin disorder—Prednisone—ankylosing spondylitis	0.000264	0.00441	CcSEcCtD
Sofosbuvir—Vision blurred—Methotrexate—ankylosing spondylitis	0.000262	0.00439	CcSEcCtD
Sofosbuvir—Anaemia—Methotrexate—ankylosing spondylitis	0.000257	0.0043	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000247	0.00414	CcSEcCtD
Sofosbuvir—Dizziness—Prednisolone—ankylosing spondylitis	0.000247	0.00414	CcSEcCtD
Sofosbuvir—Asthenia—Triamcinolone—ankylosing spondylitis	0.000246	0.00413	CcSEcCtD
Sofosbuvir—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000246	0.00413	CcSEcCtD
Sofosbuvir—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000246	0.00413	CcSEcCtD
Sofosbuvir—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000246	0.00412	CcSEcCtD
Sofosbuvir—Insomnia—Prednisone—ankylosing spondylitis	0.000245	0.00411	CcSEcCtD
Sofosbuvir—Pruritus—Triamcinolone—ankylosing spondylitis	0.000243	0.00407	CcSEcCtD
Sofosbuvir—Cough—Methotrexate—ankylosing spondylitis	0.000243	0.00406	CcSEcCtD
Sofosbuvir—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000242	0.00406	CcSEcCtD
Sofosbuvir—Dyspepsia—Prednisone—ankylosing spondylitis	0.000239	0.004	CcSEcCtD
Sofosbuvir—Arthralgia—Methotrexate—ankylosing spondylitis	0.000237	0.00396	CcSEcCtD
Sofosbuvir—Myalgia—Methotrexate—ankylosing spondylitis	0.000237	0.00396	CcSEcCtD
Sofosbuvir—Chest pain—Methotrexate—ankylosing spondylitis	0.000237	0.00396	CcSEcCtD
Sofosbuvir—Decreased appetite—Prednisone—ankylosing spondylitis	0.000236	0.00395	CcSEcCtD
Sofosbuvir—Rash—Prednisolone—ankylosing spondylitis	0.000236	0.00394	CcSEcCtD
Sofosbuvir—Dermatitis—Prednisolone—ankylosing spondylitis	0.000235	0.00394	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000235	0.00393	CcSEcCtD
Sofosbuvir—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000235	0.00393	CcSEcCtD
Sofosbuvir—Fatigue—Prednisone—ankylosing spondylitis	0.000234	0.00392	CcSEcCtD
Sofosbuvir—Headache—Prednisolone—ankylosing spondylitis	0.000234	0.00392	CcSEcCtD
Sofosbuvir—Constipation—Prednisone—ankylosing spondylitis	0.000232	0.00389	CcSEcCtD
Sofosbuvir—Dizziness—Triamcinolone—ankylosing spondylitis	0.000227	0.0038	CcSEcCtD
Sofosbuvir—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000227	0.00379	CcSEcCtD
Sofosbuvir—Infection—Methotrexate—ankylosing spondylitis	0.000225	0.00377	CcSEcCtD
Sofosbuvir—Asthenia—Betamethasone—ankylosing spondylitis	0.000224	0.00374	CcSEcCtD
Sofosbuvir—Asthenia—Dexamethasone—ankylosing spondylitis	0.000224	0.00374	CcSEcCtD
Sofosbuvir—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000222	0.00372	CcSEcCtD
Sofosbuvir—Nausea—Prednisolone—ankylosing spondylitis	0.000222	0.00371	CcSEcCtD
Sofosbuvir—Pruritus—Betamethasone—ankylosing spondylitis	0.000221	0.00369	CcSEcCtD
Sofosbuvir—Pruritus—Dexamethasone—ankylosing spondylitis	0.000221	0.00369	CcSEcCtD
Sofosbuvir—Skin disorder—Methotrexate—ankylosing spondylitis	0.00022	0.00369	CcSEcCtD
Sofosbuvir—Vomiting—Triamcinolone—ankylosing spondylitis	0.000218	0.00366	CcSEcCtD
Sofosbuvir—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000218	0.00365	CcSEcCtD
Sofosbuvir—Rash—Triamcinolone—ankylosing spondylitis	0.000217	0.00363	CcSEcCtD
Sofosbuvir—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000216	0.00362	CcSEcCtD
Sofosbuvir—Rash—Methylprednisolone—ankylosing spondylitis	0.000216	0.00362	CcSEcCtD
Sofosbuvir—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000216	0.00361	CcSEcCtD
Sofosbuvir—Headache—Triamcinolone—ankylosing spondylitis	0.000215	0.0036	CcSEcCtD
Sofosbuvir—Headache—Methylprednisolone—ankylosing spondylitis	0.000215	0.00359	CcSEcCtD
Sofosbuvir—Body temperature increased—Prednisone—ankylosing spondylitis	0.000215	0.00359	CcSEcCtD
Sofosbuvir—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000213	0.00357	CcSEcCtD
Sofosbuvir—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000213	0.00357	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000207	0.00346	CcSEcCtD
Sofosbuvir—Dizziness—Betamethasone—ankylosing spondylitis	0.000206	0.00345	CcSEcCtD
Sofosbuvir—Dizziness—Dexamethasone—ankylosing spondylitis	0.000206	0.00345	CcSEcCtD
Sofosbuvir—Insomnia—Methotrexate—ankylosing spondylitis	0.000205	0.00344	CcSEcCtD
Sofosbuvir—Nausea—Triamcinolone—ankylosing spondylitis	0.000204	0.00342	CcSEcCtD
Sofosbuvir—Nausea—Methylprednisolone—ankylosing spondylitis	0.000204	0.00341	CcSEcCtD
Sofosbuvir—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000202	0.00339	CcSEcCtD
Sofosbuvir—Dyspepsia—Methotrexate—ankylosing spondylitis	0.0002	0.00334	CcSEcCtD
Sofosbuvir—Vomiting—Dexamethasone—ankylosing spondylitis	0.000198	0.00332	CcSEcCtD
Sofosbuvir—Vomiting—Betamethasone—ankylosing spondylitis	0.000198	0.00332	CcSEcCtD
Sofosbuvir—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000197	0.0033	CcSEcCtD
Sofosbuvir—Rash—Dexamethasone—ankylosing spondylitis	0.000197	0.00329	CcSEcCtD
Sofosbuvir—Rash—Betamethasone—ankylosing spondylitis	0.000197	0.00329	CcSEcCtD
Sofosbuvir—Dermatitis—Betamethasone—ankylosing spondylitis	0.000196	0.00329	CcSEcCtD
Sofosbuvir—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000196	0.00329	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000196	0.00328	CcSEcCtD
Sofosbuvir—Fatigue—Methotrexate—ankylosing spondylitis	0.000196	0.00327	CcSEcCtD
Sofosbuvir—Headache—Dexamethasone—ankylosing spondylitis	0.000195	0.00327	CcSEcCtD
Sofosbuvir—Headache—Betamethasone—ankylosing spondylitis	0.000195	0.00327	CcSEcCtD
Sofosbuvir—Asthenia—Prednisone—ankylosing spondylitis	0.000195	0.00326	CcSEcCtD
Sofosbuvir—Pain—Methotrexate—ankylosing spondylitis	0.000194	0.00325	CcSEcCtD
Sofosbuvir—Pruritus—Prednisone—ankylosing spondylitis	0.000192	0.00322	CcSEcCtD
Sofosbuvir—Diarrhoea—Prednisone—ankylosing spondylitis	0.000186	0.00311	CcSEcCtD
Sofosbuvir—Nausea—Betamethasone—ankylosing spondylitis	0.000185	0.0031	CcSEcCtD
Sofosbuvir—Nausea—Dexamethasone—ankylosing spondylitis	0.000185	0.0031	CcSEcCtD
Sofosbuvir—Dizziness—Prednisone—ankylosing spondylitis	0.000179	0.00301	CcSEcCtD
Sofosbuvir—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000179	0.003	CcSEcCtD
Sofosbuvir—Vomiting—Prednisone—ankylosing spondylitis	0.000173	0.00289	CcSEcCtD
Sofosbuvir—Rash—Prednisone—ankylosing spondylitis	0.000171	0.00287	CcSEcCtD
Sofosbuvir—Dermatitis—Prednisone—ankylosing spondylitis	0.000171	0.00286	CcSEcCtD
Sofosbuvir—Headache—Prednisone—ankylosing spondylitis	0.00017	0.00285	CcSEcCtD
Sofosbuvir—Asthenia—Methotrexate—ankylosing spondylitis	0.000163	0.00272	CcSEcCtD
Sofosbuvir—Nausea—Prednisone—ankylosing spondylitis	0.000161	0.0027	CcSEcCtD
Sofosbuvir—Pruritus—Methotrexate—ankylosing spondylitis	0.00016	0.00269	CcSEcCtD
Sofosbuvir—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000155	0.0026	CcSEcCtD
Sofosbuvir—Dizziness—Methotrexate—ankylosing spondylitis	0.00015	0.00251	CcSEcCtD
Sofosbuvir—Vomiting—Methotrexate—ankylosing spondylitis	0.000144	0.00241	CcSEcCtD
Sofosbuvir—Rash—Methotrexate—ankylosing spondylitis	0.000143	0.00239	CcSEcCtD
Sofosbuvir—Dermatitis—Methotrexate—ankylosing spondylitis	0.000143	0.00239	CcSEcCtD
Sofosbuvir—Headache—Methotrexate—ankylosing spondylitis	0.000142	0.00238	CcSEcCtD
Sofosbuvir—Nausea—Methotrexate—ankylosing spondylitis	0.000135	0.00226	CcSEcCtD
